{
  "title": "Paper_305",
  "abstract": "pmc Sci Adv Sci Adv 2850 sciadv sciadv Science Advances 2375-2548 American Association for the Advancement of Science PMC12488054 PMC12488054.1 12488054 12488054 38019913 10.1126/sciadv.adi7375 adi7375 1 Research Article Biomedicine and Life Sciences SciAdv r-articles Stem Cells Stem Cells ROBO1 CDC42 ROBO1 loss impairs HSPC and erythropoiesis in MDS https://orcid.org/0009-0002-0610-7661 Jin Jia-Cheng Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  1 † https://orcid.org/0000-0001-9525-2021 Chen Bing-Yi Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Supervision Validation Visualization Writing - original draft Writing - review & editing  2 † Deng Chu-Han Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Chen Jia-Nan Conceptualization Formal analysis Methodology Software  1 Xu Feng Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  1 Tao Ying Resources Software Validation  1 https://orcid.org/0000-0002-2928-2625 Hu Cheng-Long Conceptualization Investigation Methodology Resources Validation Writing - review & editing  2 https://orcid.org/0000-0002-3836-3179 Xu Chun-Hui Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Chang Bin-He Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Wang Yong Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Fei Ming-Yue Investigation Methodology  2 Liu Ping Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 https://orcid.org/0000-0002-7256-2489 Yu Peng-Cheng Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Li Zi-Juan Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Li Xi-Ya Conceptualization Resources  2 Chen Shu-Bei Conceptualization Data curation Project administration Resources Software Writing - original draft  2 https://orcid.org/0000-0002-6010-9775 Jiang Yi-Lun Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Chen Xin-Chi Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Zong Li-Juan Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Zhang Jia-Ying Conceptualization Investigation Resources Software  2 Ren Yi-Yi Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 Xu Fan-Huan Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  1 Liu Qi  1 Huang Xin-Hui Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  1 Guo Juan Resources  1 He Qi Conceptualization Data curation Investigation Methodology Project administration Supervision Writing - original draft  1 Song Lu-Xi Conceptualization Investigation Methodology Writing - review & editing  1 Zhou Li-Yu Resources  1  3 Su Ji-Ying Conceptualization Formal analysis Methodology  1 Xiao Chao Conceptualization Formal analysis Methodology Software Validation Visualization  1 Zhang Yu-Mei Resources  3 Yan Meng Conceptualization Formal analysis Resources  3 Zhang Zheng Conceptualization Methodology  1 Wu Dong Conceptualization Investigation Methodology Supervision Visualization Writing - original draft  1 Chang Chun-Kang Resources  1 Li Xiao Conceptualization Resources  1 https://orcid.org/0000-0003-3545-5059 Wang Lan Conceptualization Data curation Formal analysis Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing - original draft Writing - review & editing  2 * https://orcid.org/0000-0003-1050-4774 Wu Ling-Yun Conceptualization Funding acquisition Methodology Project administration Supervision Validation Visualization Writing - original draft Writing - review & editing  1  3 * 1 2 3 * lincy2032@sjtu.edu.cn lwang@sinh.ac.cn † These authors contributed equally to this work. 01 12 2023 29 11 2023 9 48 449988 eadi7375 16 5 2023 27 10 2023 29 11 2023 02 10 2025 02 10 2025 Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2023 The Authors https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license not Myelodysplastic syndrome (MDS) is a group of clonal hematopoietic neoplasms originating from hematopoietic stem progenitor cells (HSPCs). We previously identified frequent roundabout guidance receptor 1 ( ROBO1 ROBO1 ROBO1 Robo1 Cdc42 Robo1 Cdc42 Robo1 ROBO1 CDC42 Robo1 loss causes MDS-like disease with anemia and multilineage dysplasia in mice, which predicts poor prognosis in MDS patients. http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 81670121 http://dx.doi.org/10.13039/501100001809 National Natural Science Foundation of China 22ZR1447700 National Key Research and Development Plan of China 2018YFA0107202 National Natural Science Foundation of China General Program 81970150 National Natural Science Foundation of China General Program 82170156 Shanghai Science and TechnologyInnovation Action Plan (Youth) 21XD1424500 Shanghai Science and TechnologyInnovation Action Plan (Youth) 23ZR1475500 pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes Copyeditor Judith Urtula INTRODUCTION Hematopoiesis is a complex and precise process regulated by multiple external and internal factors to coordinate self-renewal and lineage differentiation of hematopoietic stem progenitor cells (HSPCs) ( 1 2 3 4 6 7 9 10 11 Roundabout guidance receptor 1 ( ROBO1 12 ROBO1 13 15 ROBO1 13 ROBO1 Using whole-exome sequencing in patients with MDS who progressed from lower-risk to higher-risk stage, we identified ROBO1 ROBO1 16 17 ROBO1 ROBO1 18 19 ROBO1 Despite the clinical importance of ROBO1 Robo1 Robo1 Robo1 ROBO1 ROBO1 ROBO1 RESULTS Low expression of ROBO1 Given the association of inactivating ROBO1 ROBO1 ROBO1 ROBO1 ROBO1 ROBO1 20 Fig. 1A ROBO1 ROBO1 Fig. 1B ROBO1 Fig. 1C Fig. 1, D and E GSE19429 Fig. 1F ROBO1 ROBO1 Table 1 Table 2 ROBO1 Fig. 1. Low expression of ROBO1 ( A ROBO1 ROBO1 z n ROBO1 z n B ROBO1 n n C ROBO1 ROBO1 z n ROBO1 z n D ROBO1 ROBO1 z n ROBO1 z n E ROBO1 ROBO1 ROBO1 z n ROBO1 z n F ROBO1 ROBO1 z n ROBO1 z n GSE19429 G ROBO1 n H ROBO1 ROBO1 z n ROBO1 z n I ROBO1 ROBO1 wt n ROBO1 ROBO1 mut n Table 1. Multivariate analysis of survival by Cox regression. CI, confidence interval. Variable Univariate P Multivariate P HR 95% CI for HR Age (<60/>60) 0.000 0.001 3.180 1.649–6.135 Sex (male/female) 0.306 – – – Diagnose (2016 WHO Subtype) 0.000 0.005 1.541 1.141–2.079 IPSS-R (very low/low/int/high/very high) 0.000 0.000 1.734 1.284–2.341 ROBO1 expression (normal/low) 0.037 0.031 1.934 1.063–3.518 TP53 mutation (WT/mutated) 0.032 0.087 2.761 0.862–8.842 SRSF2 mutation (WT/mutated) 0.000 0.045 3.470 1.025–11.744 DNMT3a mutation (WT/mutated) 0.035 0.246 2.049 0.609–6.893 U2AF1 mutation (WT/mutated) 0.021 0.772 0.860 0.309–2.388 Table 2. Multivariate analysis of AML transformation by Cox regression. Variable Univariate P Multivariate P HR 95% CI for HR Age (<60/>60) 0.000 0.007 4.877 1.556–15.291 Sex (male/female) 0.197 – – – Diagnose (2016 WHO Subtype) 0.000 0.005 2.039 1.240–3.353 IPSS-R (very low/low/int/high/very high) 0.007 0.019 1.761 1.096–2.829 ROBO1 expression (normal/low) 0.008 0.048 2.757 1.007–7.550 TP53 mutation (WT/mutated) 0.102 0.163 3.540 0.599–20.939 SRSF2 mutation (WT/mutated) 0.000 0.009 9.334 1.768–49.294 DNMT3a mutation (WT/mutated) 0.025 0.012 6.643 1.511–29.216 U2AF1 mutation (WT/mutated) 0.022 0.354 1.007 0.256–3.961 Intriguingly, a positive association between ROBO1 Fig. 1G ROBO1 Fig. 1H ROBO1 ROBO1 mut n ROBO1 ROBO1 wt n Fig. 1I ROBO1 ROBO1 mut ROBO1 ROBO1 Robo1- To characterize the in vivo role of Robo1 Robo1 Fig. 2A Robo1 Δ/Δ Robo1 f/f Fig. 2B Robo1 Δ/Δ Fig. 2C Robo1 f/f + Robo1 Δ/Δ Fig. 2, E and F Fig. 2D Robo1 med hi hi hi hi med hi lo Robo1 Fig. 2, G and H Robo1 Robo1 f/f Robo1 Δ/Δ Robo1 Δ/Δ Fig. 2I Robo1 Robo1 Fig. 2J Fig. 2. Robo1- ( A Robo1 B Robo1 f/f Robo1 Δ/Δ C Robo1 f/f Robo1 Δ/Δ D Robo1 f/f Robo1 Δ/Δ Robo1 E F + Robo1 f/f Robo1 Δ/Δ G H Robo1 f/f Robo1 Δ/Δ I Robo1 f/f Robo1 Δ/Δ J Robo1 f/f Robo1 Δ/Δ K L P P To further assess the potential cause of blocked erythropoiesis, we detected the expression of several erythroid-specific transcription factors, and the results showed that Robo1 deficiency substantially suppressed the expression of Gfi Gfi-b Robo1 Δ/Δ Fig. 2, K and L Robo1 Δ/Δ Robo1 Through oligonucleotide microarray analysis of different types of BM cells in Blood Spot database ( 21 ROBO1 Fig. 3A Robo1 Δ/Δ Robo1 Robo1 f/f Robo1 Δ/Δ Robo1 − + − Robo1 f/f Fig. 3B Robo1 Fig. 3, C and D − − + − + Robo1 f/f Fig. 3, E and F − − + + − Fig. 3, G and H Robo1 Robo1 Δ/Δ Fig. 3. Robo1 ( A _ B − C D Robo1 f/f Robo1 Δ/Δ E F Robo1 f/f Robo1 Δ/Δ G H Robo1 f/f Robo1 Δ/Δ I J Robo1 f/f Robo1 Δ/Δ K P P Nonetheless, the reduced frequency of HSCs does not necessarily imply functional impairment of proliferation and differentiation. Therefore, we conducted a CFU assay to examine the proliferation and differentiation functions of HSCs isolated from Robo1 f/f Robo1 Δ/Δ Robo1 Robo1 Δ/Δ Fig. 3, I and J 0 2 Robo1 Δ/Δ Robo1 Fig. 3K Robo1 Robo1 Δ/Δ Robo1 Robo1 To assess in depth the impact of Robo1 Robo1 f/f Robo1 Δ/Δ 22 Fig. 4A 23 Robo1 f/f Robo1 Δ/Δ Robo1 Fig. 4, B to E + + + Fig. 4. Robo1 ( A Robo1 f/f Robo1 Δ/Δ B E Robo1 f/f Robo1 Δ/Δ F 6 Robo1 f/f Robo1 Δ/Δ 6 G Robo1 f/f Robo1 Δ/Δ H I J P P P Given the cell nonautonomous effect caused by nonhematopoietic cells in BM, we performed a competitive BM transplantation (cBMT) assay ( Fig. 4F Robo1 f/f Robo1 Δ/Δ Robo1 Δ/Δ Robo1 f/f Robo1 Δ/Δ Fig. 4G Robo1 Δ/Δ Fig. 4, H and I Robo1 Δ/Δ Fig. 4J Robo1 f/f Robo1 Δ/Δ Robo1 Robo1 We next conducted a noncompetitive BM transplantation (ncBMT) to probe the intrinsic function of Robo1 Robo1 f/f Robo1 Δ/Δ Robo1 Robo1 Δ/Δ Robo1 Δ/Δ Fig. 5A Robo1 Δ/Δ Robo1 f/f Fig. 5, B and C hi lo Fig. 5, E and F Robo1 Δ/Δ Fig. 5D Fig. 5. Robo1 ( A Robo1 f/f Robo1 Δ/Δ B Robo1 f/f Robo1 Δ/Δ C Robo1 f/f Robo1 Δ/Δ D E F med hi hi hi hi med hi lo G H + + I J Robo1 + K L M P Robo1 f/f Robo1 Δ/Δ Q P P Intriguingly, we still found a gradual proliferation of neutrophil and monocyte in PB (fig. S5C) alongside a notable expansion of Mac1 + + Robo1 Δ/Δ Fig. 5, G and H + + + Fig. 5, I to P Fig. 5Q Robo1 f/f Robo1 Δ/Δ Robo1 Robo1 Δ/Δ Robo1 Cdc42 Robo1 Δ/Δ To elucidate the cellular and molecular mechanisms underlying the pathogenic role of Robo1 Robo1 f/f Robo1 Δ/Δ Robo1 P Fig. 6A Robo1 Fig. 6. Robo1 Cdc42 Robo1 Δ/Δ ( A B Robo1 f/f Robo1 Δ/Δ C D Robo1 Δ/Δ E Robo1 Δ/Δ This is particularly the case given the emerging research suggesting that Cdc42 Robo1 14 24 Cdc42 25 26 Cdc42 Cdc4 Robo1 Δ/Δ Fig. 6B Cdc42 Arhgap1 Iqgap2 Pak1 Pak2 Pak4 Rac1 Fig. 6C Cdc42 Fig. 6D Robo1 Δ/Δ Fig. 6E Robo1 Overexpression of Cdc42 Robo1 Δ/Δ While multiple studies have confirmed the crucial role of Cdc42 Cdc42 26 29 Cdc42 Robo1 f/f Fig. 7, A and B Cdc42 Robo1 Δ/Δ Cdc42 Cdc42 oe Robo1 f/f Robo1 Δ/Δ Fig. 7, C and D Cdc42 Fig. 7E Fig. 7, F and G Fig. 7H Robo1 f/f Cdc42 + Robo1 f/f Robo1 f/f Robo1 Δ/Δ Robo1 Δ/Δ + + Robo1 Δ/Δ Robo1 f/f Fig. 7, I to K Cdc42 Robo1 Cdc42 Fig. 7. Overexpression of Cdc42 Robo1 Δ/Δ ( A B Robo1 f/f C Cdc42 Robo1 f/f Robo1 Δ/Δ + D CDC42 Robo1 f/f Robo1 Δ/Δ E Cdc42 Robo1 Δ/Δ F G H I K + L Robo1 M Nck1 N Robo1 Cdc42 P P P Robo1 We have previously identified Cdc42 Robo1 Fig. 7L 14 24 30 Nck1 Nck1 Robo1 Δ/Δ Nck1 Fig. 7M Cdc42 Robo1 Cdc42 Robo1 Δ/Δ GSE19429 HCF CDC42 HCF ROBO1 CDC42 31 HCF Robo1 f/f Robo1 Δ/Δ Robo1 DISCUSSION We had previously identified that ROBO1 ROBO1 16 ROBO1 Robo1 Robo1 Robo1 ROBO1 ROBO1 Robo1 is first identified in the nervous system, where it functions in neuronal axons, mediating guidance or repulsion signals through different ligands such as Netrin, Slit2 ( 32 33 34 35 Robo1 14 24 36 Cdc42 Robo1 Δ/Δ Cdc42 25 Cdc42 25 Cdc42 27 29 Robo1 Δ/Δ Robo1 Robo1 Intriguingly, Robo1 Δ/Δ Robo1 37 38 38 Robo1 Δ/Δ 39 40 42 Nonetheless, we did not observe prominent AML transformation in Robo1 Δ/Δ 43 46 6 47 48 Robo1 TP53 TET2, SRSF2, Here, we report that low expression of ROBO1 Robo1 Robo1 ROBO1 Fig. 7K MATERIALS AND METHODS Patients The study involved 239 patients with MDS from Shanghai Jiao Tong University Affiliated Sixth People’s Hospital from June 2009 to December 2020. cDNA samples of 21 normal controls and 111 patients with MDS from BMNCs were collected. All the participants provided written informed consent under a protocol that was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital (YS-2016-048). The microarray data were derived from GEO database ( GSE19429 ROBO1 z ROBO1 z ROBO1 z ROBO1 Mice Conditional Robo1 Robo1 f/f Robo1 Robo1 Robo1 f/f Robo1 f/f Cre + Robo1 f/f Cre − Mx1-Cre Robo1 Robo1 f/f Cre + Robo1 f/f Cre − Cell lines and cell culture 32D cells (murine HSPC cell line) were cultured in RPMI 1640 medium with 10% FBS and murine IL-3 (10 ng/ml). Murine primary BM cells were cultured in RPMI 1640 medium with 10% FBS, murine CSF (100 ng/ml), murine IL-3 (10 ng/ml), and murine IL-6 (10 ng/ml). Construction of retroviruses and lentiviruses The Cdc42 Nck1 Nck1 Flow cytometry HSPCs BM cells were first stained in PBS with 1% FCS at room temperature (RT) for 15 min with BD antibody (Ter119, B220, Gr1, CD11b, CD3, CD4, CD5, CD8, and CD127), as well as Streptavidin APC-cy7, Sca-1 BV510, c-Kit PE-cy7, CD150 PE, CD48 FITC, CD34 AF647, Flt3 PE, and CD16/32 PE at 4°C for 30 min. The antibodies for flow cytometry are listed in table S2. Myeloid and erythroid differentiation PB, BM, and spleen cells were stained in PBS at 4°C for 30 min with myeloid differentiation markers (Mac-1 APC and Gr-1 PE) or erythroid differentiation markers (Ter119 APC, CD71 PE). The antibodies for flow cytometry are listed in table S2. Cell cycle assay BM cells were first stained in PBS with 1% FCS at RT for 15 min with BD antibody (Ter119, B220, Gr1, CD11b, CD3, CD4, CD5, CD8, and CD127), as well as HSPCs surface markers and ki67 APC and 7AAD at 4°C for 30 min. The antibodies for flow cytometry are listed in table S2. Apoptosis analysis BM cells were firstly stained with erythroid differentiation markers (Ter119 APC and CD71 PE) and then stained in 1× binding buffer at RT for 15 min with apoptosis markers (annexin V FITC). The antibodies for flow cytometry are listed in table S2. CFU assay A total of 1 × 10 3 2 5 2 Co-immunoprecipitation assay For the endogenous immunoprecipitation (IP) assay, murine BMNCs and 32D cells were lysed with T/G lysis buffer [20 mM tris-HCl (pH 7.5), 300 mM NaCl, 50 mM NaF, 2 mM EDTA, 1% Triton X-100, and 20% glycerol] on ice for 40 min; then, the supernatant was incubated by adding primary antibody overnight at 4°C. The Protein A/G beads were added the next day at 4°C. The beads were washed three times and collected for subsequent immunoblotting tests. Quantitative PCR Total RNA was extracted with Trizol (Invitrogen, 15596018) and then reversely transcribed using PrimeScript RT reagent Kit (TaKaRa, RR047A). SYBR (Vazyme, Q511-03) was used in qPCR. The qPCR primers are listed in table S1. Western blot analysis The cells were lysed with a 1× Laemmlie buffer. The cell lysates were separated by SDS–polyacrylamide gel electrophoresis and transferred onto the polyvinyl difluoride membrane. The membranes were then blocked with 5% nonfat milk for 1 hour at RT and incubated sequentially with primary antibodies overnight at 4°C. The membrane was washed three times and incubated with secondary antibodies for 1 hour at RT. The antibodies are listed in table S2. Competitive BM transplantation A total of 1.5 × 10 6 Robo1 f/f Robo1 Δ/Δ 6 Noncompetitive BM transplantation A total of 3 × 10 6 Robo1 f/f 6 Robo1 Δ/Δ Robo1 RNA sequencing HSPC cells were isolated from BMNCs of Robo1 f/f Robo1 Δ/Δ Statistical tests and analysis Unpaired two-tailed t P P P Acknowledgments We thank Gem Pharmatech, Ltd. for providing assistance in constructing the mouse model. Funding: Author contributions: Competing interests: Data and materials availability: GSE231641 Supplementary Materials This PDF file includes: Figs. S1 to S8 Tables S1 to S3 REFERENCES AND NOTES 1 S. H. Orkin L. I. Zon Hematopoiesis: An evolving paradigm for stem cell biology Cell 132 631 644 2008 18295580 10.1016/j.cell.2008.01.025 PMC2628169 2 S. H. Cheshier S. J. Morrison X. Liao I. L. Weissman In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells Proc. Natl. Acad. Sci. U.S.A. 96 3120 3125 1999 10077647 10.1073/pnas.96.6.3120 PMC15905 3 M. Cazzola Myelodysplastic Syndromes N. Engl. J. Med. 383 1358 1374 2020 32997910 10.1056/NEJMra1904794 4 S. Asada T. Fujino S. Goyama T. Kitamura The role of ASXL1 in hematopoiesis and myeloid malignancies Cell. Mol. Life Sci. 76 2511 2523 2019 30927018 10.1007/s00018-019-03084-7 PMC11105736 5 M. A. Smith G. S. Choudhary A. Pellagatti K. Choi L. C. Bolanos T. D. Bhagat S. Gordon-Mitchell D. von Ahrens K. Pradhan V. Steeples S. Kim U. Steidl M. Walter I. D. C. Fraser A. Kulkarni N. Salomonis K. Komurov J. Boultwood A. Verma D. T. Starczynowski U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies Nat. Cell Biol. 21 640 650 2019 31011167 10.1038/s41556-019-0314-5 PMC6679973 6 E. Bernard Y. Nannya R. P. Hasserjian S. M. Devlin H. Tuechler J. S. Medina-Martinez T. Yoshizato Y. Shiozawa R. Saiki L. Malcovati M. F. Levine J. E. Arango Y. Zhou F. Solé C. A. Cargo D. Haase M. Creignou U. Germing Y. Zhang G. Gundem A. Sarian A. A. van de Loosdrecht M. Jädersten M. Tobiasson O. Kosmider M. Y. Follo F. Thol R. F. Pinheiro V. Santini I. Kotsianidis J. Boultwood F. P. S. Santos J. Schanz S. Kasahara T. Ishikawa H. Tsurumi A. Takaori-Kondo T. Kiguchi C. Polprasert J. M. Bennett V. M. Klimek M. R. Savona M. Belickova C. Ganster L. Palomo G. Sanz L. Ades M. G. Della Porta H. K. Elias A. G. Smith Y. Werner M. Patel A. Viale K. Vanness D. S. Neuberg K. E. Stevenson K. Menghrajani K. L. Bolton P. Fenaux A. Pellagatti U. Platzbecker M. Heuser P. Valent S. Chiba Y. Miyazaki C. Finelli M. T. Voso L.-Y. Shih M. Fontenay J. H. Jansen J. Cervera Y. Atsuta N. Gattermann B. L. Ebert R. Bejar P. L. Greenberg M. Cazzola E. Hellström-Lindberg S. Ogawa E. Papaemmanuil Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Nat. Med. 26 1549 1556 2020 32747829 10.1038/s41591-020-1008-z PMC8381722 7 S. Tara Y. Isshiki Y. Nakajima-Takagi M. Oshima K. Aoyama T. Tanaka D. Shinoda S. Koide A. Saraya S. Miyagi I. Manabe H. Matsui H. Koseki V. J. Bardwell A. Iwama Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome Blood 132 2470 2483 2018 30228234 10.1182/blood-2018-01-827964 PMC6450057 8 Y. Gu R. Yang Y. Yang Y. Zhao A. Wakeham W. Y. Li A. Tseng J. Leca T. Berger M. Saunders J. Fortin X. Gao Y. Yuan L. Xiao F. Zhang L. Zhang G. Gao W. Zhou Z. Wang T. W. Mak J. Ye IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis Blood 137 945 958 2021 33254233 10.1182/blood.2020007075 9 S. Gialesaki D. Bräuer-Hartmann H. Issa R. Bhayadia O. Alejo-Valle L. Verboon A.-L. Schmell S. Laszig E. Regényi K. Schuschel M. Labuhn M. Ng R. Winkler C. Ihling A. Sinz M. Glaß S. Hüttelmaier S. Matzk L. Schmid F. J. Strüwe S.-K. Kadel D. Reinhardt M.-L. Yaspo D. Heckl J.-H. Klusmann RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia Blood 141 1105 1118 2023 36493345 10.1182/blood.2022017619 PMC10023736 10 U. Platzbecker Treatment of MDS Blood 133 1096 1107 2019 30670446 10.1182/blood-2018-10-844696 11 S. Ogawa Genetics of MDS Blood 133 1049 1059 2019 30670442 10.1182/blood-2018-10-844621 PMC6587668 12 Z. Koohini Z. Koohini S. Teimourian Slit/Robo Signaling Pathway in Cancer; a New Stand Point for Cancer Treatment Pathol. Oncol. Res. 25 1285 1293 2019 30610466 10.1007/s12253-018-00568-y 13 S. B. Geutskens W. D. Andrews A.-M. D. van Stalborch K. Brussen S. E. Holtrop-de Haan J. G. Parnavelas P. L. Hordijk P. B. van Hennik Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3 Lab. Invest. 92 1129 1139 2012 22614124 10.1038/labinvest.2012.81 14 A. Dubrac G. Genet R. Ola F. Zhang L. Pibouin-Fragner J. Han J. Zhang J.-L. Thomas A. Chedotal M.-A. Schwartz A. Eichmann Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization Circulation 133 409 421 2016 26659946 10.1161/CIRCULATIONAHA.115.017537 PMC4729599 15 W.-J. Zhou Z. H. Geng S. Chi W. Zhang X.-F. Niu S.-J. Lan L. Ma X. Yang L.-J. Wang Y.-Q. Ding J.-G. Geng Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis Cell Res. 21 609 626 2011 21283129 10.1038/cr.2011.17 PMC3203654 16 F. Xu L.-Y. Wu C.-K. Chang Q. He Z. Zhang L. Liu W.-H. Shi J. Guo Y. Zhu Y.-S. Zhao S.-C. Gu C.-M. Fei D. Wu L.-Y. Zhou J.-Y. Su L.-X. Song C. Xiao X. Li Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes Nat. Commun. 6 8806 2015 26608094 10.1038/ncomms9806 PMC4674765 17 F. Xu L.-Y. Wu Q. He D. Wu Z. Zhang L.-X. Song Y.-S. Zhao J.-Y. Su L.-Y. Zhou J. Guo C.-K. Chang X. Li Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes Sci. Rep. 7 43113 2017 28220884 10.1038/srep43113 PMC5318910 18 A. Gołos D. Jesionek-Kupnicka L. Gil M. Braun M. Komarnicki T. Robak A. Wierzbowska The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia Arch. Immunol. Ther. Exp. (Warsz.) 67 109 123 2019 30820596 10.1007/s00005-019-00535-8 PMC6420492 19 T. L. Dunwell R. E. Dickinson T. Stankovic A. Dallol V. Weston B. Austen D. Catchpoole E. R. Maher F. Latif Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia Epigenetics 4 265 269 2009 19550140 10.4161/epi.9137 20 P. L. Greenberg H. Tuechler J. Schanz G. Sanz G. Garcia-Manero F. Solé J. M. Bennett D. Bowen P. Fenaux F. Dreyfus H. Kantarjian A. Kuendgen A. Levis L. Malcovati M. Cazzola J. Cermak C. Fonatsch M. M. le Beau M. L. Slovak O. Krieger M. Luebbert J. Maciejewski S. M. M. Magalhaes Y. Miyazaki M. Pfeilstöcker M. Sekeres W. R. Sperr R. Stauder S. Tauro P. Valent T. Vallespi A. A. van de Loosdrecht U. Germing D. Haase Revised international prognostic scoring system for myelodysplastic syndromes Blood 120 2454 2465 2012 22740453 10.1182/blood-2012-03-420489 PMC4425443 21 F. O. Bagger S. Kinalis N. Rapin BloodSpot: A database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles Nucleic Acids Res. 47 D881 D885 2019 30395307 10.1093/nar/gky1076 PMC6323996 22 A. Shaikh D. Bhartiya S. Kapoor H. Nimkar Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells Stem Cell Res Ther 7 59 2016 27095238 10.1186/s13287-016-0311-6 PMC4837595 23 D. Zhang X. Gao H. Li D. K. Borger Q. Wei E. Yang C. Xu S. Pinho P. S. Frenette The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow Cell Stem Cell 29 232 247.e7 2022 35065706 10.1016/j.stem.2021.12.009 PMC8818037 24 X. Fan J. P. Labrador H. Hing G. J. Bashaw Slit stimulation recruits Dock and Pak to the roundabout receptor and increases Rac activity to regulate axon repulsion at the CNS midline Neuron 40 113 127 2003 14527437 10.1016/s0896-6273(03)00591-9 25 L. Yang L. Wang T. A. Kalfa J. A. Cancelas X. Shang S. Pushkaran J. Mo D. A. Williams Y. Zheng Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis Blood 110 3853 3861 2007 17702896 10.1182/blood-2007-03-079582 PMC2190607 26 K. Ubukawa T. Goto K. Asanuma Y. Sasaki Y.-M. Guo I. Kobayashi K. Sawada H. Wakui N. Takahashi Cdc42 regulates cell polarization and contractile actomyosin rings during terminal differentiation of human erythroblasts Sci. Rep. 10 11806 2020 32678227 10.1038/s41598-020-68799-1 PMC7366696 27 M. C. Florian K. Dörr A. Niebel D. Daria H. Schrezenmeier M. Rojewski M.-D. Filippi A. Hasenberg M. Gunzer K. Scharffetter-Kochanek Y. Zheng H. Geiger Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation Cell Stem Cell 10 520 530 2012 22560076 10.1016/j.stem.2012.04.007 PMC3348626 28 W. Liu W. du X. Shang L. Wang C. Evelyn M. C. Florian M. A. Ryan A. Rayes X. Zhao K. Setchell J. Meller F. Guo N. Nassar H. Geiger Q. Pang Y. Zheng Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization Leukemia 33 749 761 2019 30254339 10.1038/s41375-018-0251-5 PMC6414073 29 A. Amoah A. Keller R. Emini M. Hoenicka A. Liebold A. Vollmer K. Eiwen K. Soller V. Sakk Y. Zheng M.-C. Florian H. Geiger Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity Haematologica 107 393 402 2022 33440922 10.3324/haematol.2020.269670 PMC8804569 30 L. Yang G. J. Bashaw Son of sevenless directly links the Robo receptor to rac activation to control axon repulsion at the midline Neuron 52 595 607 2006 17114045 10.1016/j.neuron.2006.09.039 31 P. Xiang F. Li Z. Ma J. Yue C. Lu Y. You L. Hou B. Yin B. Qiang P. Shu X. Peng HCF-1 promotes cell cycle progression by regulating the expression of CDC42 Cell Death Dis. 11 907 2020 33097698 10.1038/s41419-020-03094-5 PMC7584624 32 X. P. Dun D. B. Parkinson Classic axon guidance molecules control correct nerve bridge tissue formation and precise axon regeneration Neural Regen. Res. 15 6 9 2020 31535634 10.4103/1673-5374.264441 PMC6862410 33 T. Kidd K. Brose K. J. Mitchell R. D. Fetter M. Tessier-Lavigne C. S. Goodman G. Tear Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors Cell 92 205 215 1998 9458045 10.1016/s0092-8674(00)80915-0 34 J. A. Legg J. M. Herbert P. Clissold R. Bicknell Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration Angiogenesis 11 13 21 2008 18264786 10.1007/s10456-008-9100-x 35 G. Narayan C. Goparaju H. Arias-Pulido A. M. Kaufmann A. Schneider M. Dürst M. Mansukhani B. Pothuri V. V. Murty Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression Mol. Cancer 5 16 2006 16700909 10.1186/1476-4598-5-16 PMC1482714 36 T. S. Chiang M.-C. Lin M.-C. Tsai C.-H. Chen L.-T. Jang F.-J. S. Lee ADP-ribosylation factor-like 4A interacts with Robo1 to promote cell migration by regulating Cdc42 activation Mol. Biol. Cell 30 69 81 2019 30427759 10.1091/mbc.E18-01-0001 PMC6337904 37 W. Dameshek Riddle: What do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \"hypoplastic\" leukemia have in common? Blood 30 251 254 1967 6031145 38 K. De Keersmaecker S. O. Sulima J. D. Dinman Ribosomopathies and the paradox of cellular hypo- to hyperproliferation Blood 125 1377 1382 2015 25575543 10.1182/blood-2014-10-569616 PMC4342353 39 L. Zhang H. Luo H.-M. Ni S. Liu H. Xing J. Zhang M. Sellin P. S. J. Breslin W. Wei M. F. Denning W. Small Jr. W.-X. Ding S. Huang J. Zhang Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice Stem Cell Reports 17 1428 1441 2022 35561683 10.1016/j.stemcr.2022.04.009 PMC9213819 40 Y.-L. Zhang J.-W. Sun Y.-Y. Xie Y. Zhou P. Liu J.-C. Song C.-H. Xu L. Wang D. Liu A.-N. Xu Z. Chen S.-J. Chen X.-J. Sun Q.-H. Huang Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation Cell Res. 28 476 490 2018 29531312 10.1038/s41422-018-0015-9 PMC5939047 41 M. E. Varney M. Niederkorn H. Konno T. Matsumura J. Gohda N. Yoshida T. Akiyama S. Christie J. Fang D. Miller A. Jerez A. Karsan J. P. Maciejewski R. A. Meetei J.-I. Inoue D. T. Starczynowski Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling J. Exp. Med. 212 1967 1985 2015 26458771 10.1084/jem.20141898 PMC4612089 42 H. Lawson C. Sepulveda L. N. van de Lagemaat J. Durko M. Barile A. Tavosanis E. Georges A. Shmakova P. Timms R. N. Carter L. Allen J. Campos M. Vukovic A. V. Guitart P. Giles M. O’Shea D. Vernimmen N. M. Morton N. P. Rodrigues B. Göttgens C. J. Schofield A. Lengeling D. O’Carroll K. R. Kranc JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells Blood Adv. 5 889 899 2021 33560400 10.1182/bloodadvances.2020002702 PMC7876897 43 M. A. S. Moore Converging pathways in leukemogenesis and stem cell self-renewal Exp. Hematol. 33 719 737 2005 15963848 10.1016/j.exphem.2005.04.011 44 N. Watanabe-Okochi J. Kitaura R. Ono H. Harada Y. Harada Y. Komeno H. Nakajima T. Nosaka T. Inaba T. Kitamura AML1 mutations induced MDS and MDS/AML in a mouse BMT model Blood 111 4297 4308 2008 18192504 10.1182/blood-2007-01-068346 45 F. Huang J. Sun W. Chen L. Zhang X. He H. Dong Y. Wu H. Wang Z. Li B. Ball S. Khaled G. Marcucci L. Li TET2 deficiency promotes MDS-associated leukemogenesis Blood Cancer J. 12 141 2022 36195586 10.1038/s41408-022-00739-w PMC9532431 46 J. Wang Z. Li Y. He F. Pan S. Chen S. Rhodes L. Nguyen J. Yuan L. Jiang X. Yang O. Weeks Z. Liu J. Zhou H. Ni C.-L. Cai M. Xu F.-C. Yang Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice Blood 123 541 553 2014 24255920 10.1182/blood-2013-05-500272 PMC3901067 47 D. G. Gilliland J. D. Griffin Role of FLT3 in leukemia Curr. Opin. Hematol. 9 274 281 2002 12042700 10.1097/00062752-200207000-00003 48 C. Schessl V. P.-S. Rawat M. Cusan A. Deshpande T. M. Kohl P. M. Rosten K. Spiekermann R. K. Humphries S. Schnittger W. Kern W. Hiddemann L. Quintanilla-Martinez S. K. Bohlander M. Feuring-Buske C. Buske The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice J. Clin. Invest. 115 2159 2168 2005 16025155 10.1172/JCI24225 PMC1174917 ",
  "metadata": {
    "Title of this paper": "The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice",
    "Journal it was published in:": "Science Advances",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12488054/"
  }
}